Tag: Protein kinase inhibitors

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Protein kinase inhibitors

MonarchE Update Benefit of Abemaciclib Increases Over Time - The ASCO Post

Added to Collection on: 2022-12-11 15:46:43

Tags for this article:

Chemical compounds
Protein kinase inhibitors
Chemistry
Clinical medicine
Breakthrough therapy
Piperazines
Abemaciclib
Benzimidazoles
Pyridines
Adjuvant therapy
Breast cancer
Stephen R.D. Johnston

Click the tags to see associated articles and topics

View Article Details
BioNTech SE Stock Up Momentum With A 9% Rise At Session Start On Tuesday | Via News

Added to Collection on: 2022-12-13 15:58:40

Tags for this article:

Breast cancer
Triple-negative breast cancer
Protein kinase inhibitors
AXL receptor tyrosine kinase
CDK inhibitor
BioNTech SE

Click the tags to see associated articles and topics

View Article Details
Astex and AstraZeneca deliver 'landmark' breast cancer drug - Cambridge Independent

Added to Collection on: 2022-12-15 19:10:04

Tags for this article:

Chemical compounds
Cancer
Clinical medicine
Protein kinase inhibitors
RTT
Breast cancer
AstraZeneca
Institute of Cancer Research
University of London
Astex
Breast cancer management
Metastatic breast cancer
Harren Jhoti
Astex Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Lorlatinib Market Brief Analysis By Top Leading Companies | Pfizer - Digital Journal

Added to Collection on: 2022-12-20 14:31:59

Tags for this article:

Protein kinase inhibitors
Business
Lorlatinib
Pyridines
Pyrroles
Articles
Economy
Market analysis
Market research
Market segmentation
Compound annual growth rate
Marketing

Click the tags to see associated articles and topics

View Article Details
Arvinas falls 17% after early-stage data for Pfizer-partnered tumor therapy - Seeking Alpha

Added to Collection on: 2023-01-09 19:48:22

Tags for this article:

Chemical compounds
Organic compounds
Branches of biology
Protein kinase inhibitors
Cell cycle
Cyclopentanes
Piperazines
Specialty drugs
Palbociclib
HER2/neu
Cyclin-dependent kinase
CDK inhibitor
Pfizer
arvinas

Click the tags to see associated articles and topics

View Article Details
Dr. Reddy's acquires Pfizer's breast cancer drug rights - The Hindu

Added to Collection on: 2023-01-13 15:43:19

Tags for this article:

Chemical compounds
Organic compounds
Protein kinase inhibitors
Piperazines
Cyclopentanes
Breakthrough therapy
Aminopyridines
Palbociclib
Cyclin-dependent kinase
Breast cancer
Dr. Reddy's Laboratories
HER2/neu
Pfizer Products

Click the tags to see associated articles and topics

View Article Details
Dr Reddy's acquires trademark rights of breast cancer drug Primcyv from Pfizer to use in India

Added to Collection on: 2023-01-13 15:17:15

Tags for this article:

Chemical compounds
Organic compounds
Health
Protein kinase inhibitors
Cyclopentanes
Piperazines
Specialty drugs
Lactams
Palbociclib
Dr. Reddy's Laboratories
Cyclin-dependent kinase
Pfizer
Reddy
Dr. Reddy?s Laboratories Ltd
Pfizer Products

Click the tags to see associated articles and topics

View Article Details
Roche's inavolisib combination reduces the risk of disease progression by 57% in ... - Yahoo Finance

Added to Collection on: 2023-12-08 22:22:09

Tags for this article:

Amides
Specialty drugs
Aminopyridines
Breakthrough therapy
Protein kinase inhibitors
Palbociclib
Phosphoinositide 3-kinase inhibitor
Alpelisib
Fulvestrant
Breast cancer
Triple-negative breast cancer
PI3K/AKT/mTOR pathway
F. Hoffmann-La Roche
San Antonio
Roche Group

Click the tags to see associated articles and topics

View Article Details
Inavolisib Plus Palbociclib and Fulvestrant Improves PFS in PIK3CA-Mutated HR+ Breast Cancer

Added to Collection on: 2023-12-08 18:14:54

Tags for this article:

Aminopyridines
Protein kinase inhibitors
Breakthrough therapy
Amides
Palbociclib
Fulvestrant
Genentech
Breast cancer
HER2
Inavolisib
Buparlisib
Phosphoinositide 3-kinase inhibitor

Click the tags to see associated articles and topics

View Article Details
BerGenBio commences Phase IIa portion of bemcentinib trial for NSCLC

Added to Collection on: 2024-03-21 16:52:18

Tags for this article:

Lung cancer
Protein kinase inhibitors
Tyrosine kinase receptors
Antineoplastic drugs
Orphan drugs
AXL receptor tyrosine kinase
Bemcentinib
Non-small-cell lung cancer
Pembrolizumab

Click the tags to see associated articles and topics

View Article Details